Product Information
RABEPRAZOLE SOD DR 20 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.2238 per EA under NDC 65862072190. Its NADAC has been published 388 times since May 1, 2019.
FDA first approved this application on Feb 17, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862072190
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
RABEPRAZOLE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA205761FDA Approved
2/17/2017
TE Code
AB
On Market Since
2/17/2017
Pharmacological Classes
Price Statistics
The NADAC for RABEPRAZOLE SOD DR 20 MG TAB has been published 388 times since May 1, 2019, and over the history we have for it it has declined 38.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2238 per EA |
|---|---|
| All-time high | $0.4100 (Mar 11, 2020) |
| All-time low | $0.1556 (Nov 20, 2024) |
| 52-week high | $0.2419 |
| 52-week low | $0.2093 |
| Median price | $0.2374 |
| Average price | $0.2527 |
| Largest weekly change | -37.7% (Jul 17, 2024) |
| Weeks tracked | 388 |
| Tracking since | May 1, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Aurobindo Pharma Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rabeprazole Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RABEPRAZOLE SOD DR 20 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for RABEPRAZOLE SOD DR 20 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.2238 per EA (NDC 65862072190), effective Sep 30, 2026.
How has the price of RABEPRAZOLE SOD DR 20 MG TAB changed over time?
Over the history we have for it, the NADAC for RABEPRAZOLE SOD DR 20 MG TAB has declined 38.5%. It has been tracked across 388 weekly CMS publications since May 1, 2019.
What are the highest and lowest recorded NADAC prices for RABEPRAZOLE SOD DR 20 MG TAB?
Since May 1, 2019, the NADAC for RABEPRAZOLE SOD DR 20 MG TAB has ranged from a low of $0.1556 (Nov 20, 2024) to a high of $0.4100 (Mar 11, 2020), with a median of $0.2374 per EA.
Are there cheaper alternatives to RABEPRAZOLE SOD DR 20 MG TAB?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RABEPRAZOLE SOD DR 20 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures RABEPRAZOLE SOD DR 20 MG TAB?
RABEPRAZOLE SOD DR 20 MG TAB (NDC 65862072190) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.